From appearance to essence: 10 years review of atypical amniotic fluid embolism

详细信息    查看全文

• 作者：Fangrong Shen ; Lu Wang ; Weiwen Yang ; Youguo Chen
• 关键词：Amniotic fluid embolism ; Maternal mortality ; Classification ; Presentation
• 刊名：Archives of Gynecology and Obstetrics
• 出版年：2016
• 出版时间：February 2016
• 年：2016
• 卷：293
• 期：2
• 页码：329-334
• 全文大小：356 KB
• 参考文献：1.Clark SL (2010) Amniotic fluid embolism. Clin Obstet Gynecol 53(2):322–328. doi:10.​1097/​GRF.​0b013e3181e0ead2​ PubMed CrossRef
  2.Conde-Agudelo A, Romero R (2009) Amniotic fluid embolism: an evidence-based review. Am J Obstet Gynecol 201 (5):445 e441–e413. doi:10.​1016/​j.​ajog.​2009.​04.​052
  3.Kahyaoglu I, Kahyaoglu S, Mollamahmutoglu L (2009) Factor VIIa treatment of DIC as a clinical manifestation of amniotic fluid embolism in a patient with fetal demise. Arch Gynecol Obstet 280(1):127–129. doi:10.​1007/​s00404-008-0857-3 PubMed CrossRef
  4.Yang W, Zhou N, Zhou Y (2000) The clinical analysis of 38 cases with amniotic fluid embolism. Zhonghua fu chan ke za zhi 35(2):75–78PubMed
  5.Prosper SC, Goudge CS, Lupo VR (2007) Recombinant factor VIIa to successfully manage disseminated intravascular coagulation from amniotic fluid embolism. Obstetr Gynecol 109(2 Pt2):524–525. doi:10.​1097/​01.​AOG.​0000235711.​11817.​8c
  6.Martin RW (1996) Amniotic fluid embolism. Clin Obstet Gynecol 39(1):101–106PubMed CrossRef
  7.Margarson MP (1995) Delayed amniotic fluid embolism following caesarean section under spinal anaesthesia. Anaesthesia 50(9):804–806PubMed CrossRef
  8.Yang CY, Chou CW, Lin MB, Lin CN, Wang LW, Chen SY, Cheng HM (2004) Recurrent pulmonary embolism in an elderly patient with Cushing’s syndrome, adrenocortical adenoma, pheochromocytoma and prostate adenocarcinoma. J Chin Med Assoc JCMA 67(7):360–365PubMed
  9.Clark SL, Hankins GD, Dudley DA, Dildy GA, Porter TF (1995) Amniotic fluid embolism: analysis of the national registry. Am J Obstetr Gynecol 172(4 Pt 1):1158–1167 discussion 1167–1159 CrossRef
  10.Nakagami H, Kajihara T, Kamei Y, Ishihara O, Kayano H, Sasaki A, Itakura A (2014) Amniotic components in the uterine vasculature and their role in amniotic fluid embolism. J Obstetr Gynaecol Res. doi:10.​1111/​jog.​12650
  11.Chen KB, Chang SS, Tseng YL, Chiu TH, Liao CC, Ho M, Huang GS, Li CY (2013) Amniotic fluid induces platelet-neutrophil aggregation and neutrophil activation. Am J Obstetr Gynecol 208(4):318 e311–317. doi:10.​1016/​j.​ajog.​2013.​01.​012
  12.Benson MD (2012) Current concepts of immunology and diagnosis in amniotic fluid embolism. Clin Dev Immunol 2012:946576. doi:10.​1155/​2012/​946576 PubMed PubMedCentral CrossRef
  13.Kanayama N, Inori J, Ishibashi-Ueda H, Takeuchi M, Nakayama M, Kimura S, Matsuda Y, Yoshimatsu J, Ikeda T (2011) Maternal death analysis from the Japanese autopsy registry for recent 16 years: significance of amniotic fluid embolism. J Obstetr Gynaecol Res 37(1):58–63. doi:10.​1111/​j.​1447-0756.​2010.​01319.​x CrossRef
  14.Davies S (1999) Amniotic fluid embolism and isolated disseminated intravascular coagulation. Can J Anaesth Journal canadien d’anesthesie 46 (5 Pt 1):456–459. doi:10.​1007/​BF03012944
  15.Clark SL, Pavlova Z, Greenspoon J, Horenstein J, Phelan JP (1986) Squamous cells in the maternal pulmonary circulation. Am J Obstet Gynecol 154(1):104–106PubMed CrossRef
  16.Knight M, Tuffnell D, Brocklehurst P, Spark P, Kurinczuk JJ, System UKOS (2010) Incidence and risk factors for amniotic-fluid embolism. Obstet Gynecol 115(5):910–917. doi:10.​1097/​AOG.​0b013e3181d9f629​ PubMed CrossRef
  17.Taylor FB, Jr., Toh CH, Hoots WK, Wada H, Levi M, Scientific Subcommittee on Disseminated Intravascular Coagulation of the International Society on T, Haemostasis (2001) Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 86 (5):1327–1330
  18.Lurie S, Feinstein M, Mamet Y (2000) Disseminated intravascular coagulopathy in pregnancy: thorough comprehension of etiology and management reduces obstetricians’ stress. Arch Gynecol Obstet 263(3):126–130. doi:10.​1007/​s004040050010 PubMed CrossRef
  19.Phillips LE, McLintock C, Pollock W, Gatt S, Popham P, Jankelowitz G, Ogle R, Cameron PA, Australian New Zealand, Haemostasis R (2009) Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry. Anesth Analg 109(6):1908–1915. doi:10.​1213/​ANE.​0b013e3181c039e6​ PubMed CrossRef
  20.Knight M, Fitzpatrick K, Kurinczuk JJ, Tuffnell D (2012) Use of recombinant factor VIIa in patients with amniotic fluid embolism. Anesthesiology 117(2):423. doi:10.​1097/​ALN.​0b013e31825b6c77​ author reply 423–424 PubMed CrossRef
  
• 作者单位：Fangrong Shen (1) (2)
  Lu Wang (1)
  Weiwen Yang (1)
  Youguo Chen (1)
  
  1. Department of Obstetrics and Gynecology, The First Affiliated Hospital of Soochow University, 118 Shizi Street, Suzhou, 215006, Jiangsu, China
  2. Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Gynecology
  Obstetrics and Perinatology
  Endocrinology
  Human Genetics
  
• 出版者：Springer Berlin / Heidelberg
• ISSN：1432-0711

文摘

Purpose Amniotic fluid embolism (AFE) is an unpredictable and unpreventable complication of maternity. The presentation may range from relatively subtle clinical events to sudden maternal cardiac arrest. However, the neglected diagnosis of non-classical form of AFE (atypical AFE) is very common. The aim of this study was to examine population-based regional data from Suzhou, China. Based on the analysis of all available case reports, we put forward an outline of atypical AFE and investigate whether any variation identified could be ascribed to methodology.